Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Orion Corporation: The Board of Directors of Orion Corporation decided on incentive programs for the company’s key persons
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Notice to the Annual General Meeting of Orion Corporation
-
Allot Partnering with Verizon Business on Enhanced Cybersecurity Protection for Its Customers’ Mobile Devices
-
Fortuna reports a fatal accident at its Séguéla Mine, Côte d’Ivoire
-
ITI Launches Master’s in Trading Program for Ambitious Traders Aspiring to Go Professional
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
ITM to Present Top Line Results from Phase 3 COMPETE Trial with [177Lu]Lu-edotreotide for the Treatment of Grade 1 & Grade 2 Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at European Neu
-
Streetleaf Becomes a National Vendor for Forestar; Brings New Solar-Powered, Innovative and Cost-Effective Streetlights as an Option to Communities Nationwide
-
Disclosure of trading in own shares from February 20, 2025 to February 21, 2025
-
ITM to Present Top Line Results from Phase 3 COMPETE Trial with [177Lu]Lu-edotreotide for the Treatment of Grade 1 & Grade 2 Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at European Neuroen
-
Orion Group Financial Statement Release January–December 2024
-
Bitget Enhances Recruitment Efficiency with AI, Cutting Hiring Time by 38%
-
Colliers promotes Felix von Saucken to CEO of Germany
-
AKVA group ASA: Key information relating to cash dividend
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
AMYRA Publishes Landmark Review Supporting New Gluten Digestion Approach for Celiac Disease
-
Offer for subscription update
-
Share Buyback Transaction Details February 20 – February 24, 2025
-
Form 8.5 (EPT/RI)-De La Rue plc
-
Form 8.5 (EPT/RI)-Alliance Pharma plc
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings Inc
-
No. 2/2025 - Publication of annual report
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Auto brands from China Auto Valley eye faster growth
-
Karolinska Development’s portfolio company AnaCardio includes first patient in a phase 2a study of its drug candidate AC01
-
Futu to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
-
New Application Extends Zscaler Exposure Management Solution, Providing a Single Platform for Asset Risk Management, Prioritization and Quantification
-
CancerVax Announces Successful Tests of its Smart mRNA Technology
-
Nokia, Vodafone and RingCentral to showcase future of voice calls at Mobile World Congress #MWC25
-
Rocket Doctor Approved as In-Network Provider for New York Medicaid, Expands Partnership with EngageWell to Enhance Care
-
Innofactor wins contract to provide the case and document management system for Gävle Municipality
-
Municipality Finance issues EUR 15 million notes under its MTN programme
-
PCI Biotech: Invitation to preliminary full-year 2024 results presentation
-
Opdateret finanskalender 2025
-
Notification of executives and related parties’ transactions with Nilfisk shares
-
Teledyne e2v announces new high-speed sensor with extended sensitivity in NIR wavelengths
-
Progress on share buyback programme
-
Aktsiaselts Infortar Unaudited Consolidated Interim Report for fourth quarter and 12 months of 2024
-
KPN commences EUR 250m share buyback
-
Invitation to Enefit Green investor webinars presenting unaudited 2024 results
-
NB Private Equity Partners Announces Transaction in Own Shares
-
Equinor ASA: Share buy-back – first tranche for 2025
-
Agillic publishes its annual results 2024 in line with preliminary results published on 6 February 2025
-
F2i and Jetex sign agreement for the development and management of general aviation in Naples and Salerno
-
BlackLine Expands Bengaluru Operations to Drive Global Growth and Innovation
-
SpyneAI Inc. Raises $16M Series A to Grow Across the U.S. and Transform Automotive Retail with GenAI
-
Transaction in Own Shares
-
BUREAU VERITAS - 2024 annual results - Bureau Veritas' LEAP | 28 strategy delivers outstanding results in 2024 ; confident 2025 outlook
-
ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy

